Since we last reviewed the drug treatment of Parkinson's disease in 1995,1 several new drugs have been licensed for its treatment, more is known about the use of levodopa plus selegiline, and new surgical techniques have been developed. Here we review these new developments and consider how they affect patient management.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.